MedPath

The effect of daily electroconvulsive therapy in patients with refractory schizophrenia

Phase 2
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT2016090823705N7
Lead Sponsor
Vice chancellor for research, Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
14
Inclusion Criteria

Diagnosis of refractory schizophrenia; range of age 18-65 years old; tendency to participate in the project. Exclusion criteria : positive history of seizure or epilepsy that needed to persistent treatment; active blood Dyskrazy; leukopeny; obstructive pulmonary disease or Pulmonary emphysema; cardiovascular disease or myocardial infarction; hepatic or renal failure; urinary obstruction; closed angle glaucoma; toxic psychosis; moderate to severe mental retardation; other psychiatric co-morbidity

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Schizophrenia symptoms. Timepoint: The beginning of the study (baseline) and end of the study (week two). Method of measurement: Brief Psychiatric Rating Scale (BPRS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath